期刊文献+

全基因组高分辨率染色体微阵列分析在超声结构异常胎儿中的应用 被引量:6

Application of whole-genome and high-resolution chromosome microarray analysis for the investigation of fetuses with ultrasound abnormalities
原文传递
导出
摘要 目的探讨全基因组高分辨率染色体微阵列分析(chromosome microarray analysis,CMA)技术在先天性结构异常胎儿中的应用价值。方法应用美国Affymetrix公司全基因组高分辨率CytoScanHD芯片对651例孕期超声检查提示先天性结构发育异常,但常规染色体核型分析未见异常的胎儿病例进行基因组学研究。包括发生单一畸形者264例,多发畸形者387例。其中产前绒毛样本130例,羊水样本192例,脐血样本329例。全部胎儿样本DNA的提取及CMA实验操作流程均按照生产商提供的标准流程操作。CMA分析所发现的拷贝数变异(copy number variants,CNVs)都进一步通过荧光原位杂交或实时荧光定量PCR反应进行验证。结果CMA分析发现475例(73%)胎儿的基因组发生拷贝数变异;其中75例(11.5%)胎儿发现与临床疾病相关的致病性CNVs,包括2例单亲二倍体和2例隐匿性的嵌合体;另外13例(2.0%)胎儿病例中发现临床意义不明确的拷贝数变异。结论全基因组高分辨率CMA在超声结构异常胎儿的遗传学分析中具有重要的应用价值,能够将检出率提高11.5%左右。应用单核苷酸多态性芯片对单亲二倍体和低水平的嵌合体均具有独特的检出能力。实验操作人员和遗传咨询医生之间的充分交流,结合家系分析以及内外数据库之间的比对能够显著降低临床意义不明确的CNVs。 Objective To assess the value of whole-genome high-resolution chromosome microarray analysis (CMA) for the investigation of fetuses with ultrasound abnormalities. Methods Whole genome high-resolution CytoScanHD array from Affymetrix was employed to investigate 651 fetuses with structural abnormalities detected by ultrasound, for whom standard G-banded chromosome analysis has revealed a normal karyotype. The fetuses were divided into a single malformation group (n= 264) and a multiple malformations group (n=387). In total there were 130 chorionic villus samples, 192 amniotic fluid samples and 329 cord blood samples. Extraction of fetal DNA and CMA experiment have followed the standard guidelines from the manufacturers. All copy number variations (CNVs) detected by CMA were confirmed by fluorescence in situ hybridization (FISH) or real-time polymerase chain reaction (RT-PCR). Results CMA analysis has detected genomic CNVs in 475 (73 %) cases. Clinically significant CNVs were found in 11.5% (76/651) of fetuses, including two uniparental disomies (UPD) and two cryptic mosaieisms. Variations of unknown significance (VOUS) was found in 2.0% (13/651) of tested fetuses. Conclusion Above results have suggested that whole-genome and high-resolution CMA is valuable for the analysis of fetuses with structural abnormalities detected by ultrasound, which can increase the detection rate by approximately 11%. CMA using single nucleotide polymorphism (SNP) array has the ability to detect UPD and low-level mosaieisms. Sufficient communication between technicians and genetic counselors, parental testing and comparison the results with in-house and relevant online databases can significantly reduce the rate of VOUS.
出处 《中华医学遗传学杂志》 CAS CSCD 北大核心 2015年第2期169-174,共6页 Chinese Journal of Medical Genetics
基金 广州市科信局民生重大项目(201300000086) 广州市卫生局重点项目(201102A212026) 东莞市医学重点项目(2012105102003)
关键词 产前诊断 染色体微阵列分析 染色体微缺失 染色体微重复 单亲二倍体 嵌合体 Prenatal diagnosis Chromosome mieroarray analysis Microdeletion Microduplication Uniparental disomy Mosaicism
  • 相关文献

参考文献28

  • 1Kalter H, Warkany J. Medical progress. Congenital malformations: etiologic factors and their role in prevention (first of two parts)[J]. N Engl J Med,1983,308(8) :424-431.
  • 2Dallaire L, Michaud J, Melaneon SB, et al. Prenatal diagnosis of fetal anomalies during the second trimester of pregnancy: their characterization and delineation of defects in pregnancies at risk [J]. Prenat Diagn,1991,11(8) :629-635.
  • 3Wilson RD, Chitayat D, McGillivray BC. Fetal ultrasound abnormalities: correlation with fetal karyotype, autopsy findings, and postnatal outcome - five-year prospective study[J]. Am J Med Genet,1992,44(5) :586-590.
  • 4Rizzo N, Pittalis MC, Pilu G, et al. Distribution of abnormal karyotypes among malformed fetuses detected by ultrasound throughout gestation[J]. Prenat Diagn, 1996,16(2) : 159-163.
  • 5Tseng JJ, Chou MM, Lo FC, et al. Detection of chromosome aberrations in the second trimester using genetic amniocentesis: experience during 1995-2004[J]. Taiwan J Obstet Gyneeol, 2006, 45(1) :39-41.
  • 6Moore KL, Persaud TVN, Torchia MG. The developing human: clinically oriented embryology[M]. Philadelphia, PA: Saunders/Elsevier, 2008.
  • 7Sagoo GS, Butterworth AS, Sanderson S, et al. Array CGH in patients with learning disability (mental retardation) and congenital anomalies: updated systematic review and meta- analysis of 19 studies and 13,926 subjects[J]. Genet Med, 2009,11 (3) : 139-146.
  • 8Miller DT, Adam MP, Aradhya S, et al. Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies[J]. Am J Hum Genet, 2010, 86(5) :749-764.
  • 9CoppingerJ, Alliman S, Lamb AN, et al. Whole-genome microarray analysis in prenatal specimens identifies clinically significant chromosome alterations without increase in results of unclear significance compared to targeted microarray[J]. Prenat Diagn, 2009, 29(12) : 1156-1166.
  • 10EvangelidouP, Sismani C, Ioannides M, et al. Clinical application of whole-genome array CGH during prenatal diagnosis: Study of 25 selected pregnancies with abnormal ultrasound findings or apparently balanced structural aberrations [J]. /Viol Cytogenet, 2010, 3:24.

同被引文献43

引证文献6

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部